Skip to content

Evolus EOLS Earnings yield

Earnings yield at other companies

AbbVie logo
AbbVieABBV
0.9%-0.2pp

Other financials

Income statement

See full
Revenue$73.1M+6.7%
Gross profit$48.9M+4.8%
Operating income-$6.8M+54.9%
Net income-$10.7M+43.5%
EPS (diluted)-$0.16+46.7%

Balance sheet

See full
Cash & equivalents$49.8M-26.7%
Total debt$164.9M-4.1%
Total equity-$28.8M-336%
Total assets$220.6M+3.4%

Cash flow

See full
Operating cash flow-$10.0M+36.3%
CapEx$415.0K+30.1%
Free cash flow-$10.4M+35.0%

Valuation

See full
Market cap$470.86M-21.3%
Enterprise value$585.97M-16.6%
P/S1.6×-0.6×

Profitability

See full
Gross margin66.1%-2.4pp
Operating margin-13.7%-1.9pp
Net margin-14.4%-3.3pp
FCF margin-9.6%-3.6pp

Returns & leverage

See full
Return on equity-472.6%-1,534pp
Debt / equity22.2×
Current ratio-0.3×

Where this comes from

Calculated from Evolus’s reported figures.

Based on trailing twelve months.

The official record: Evolus’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evolus's earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Evolus's earnings yield?
Evolus (EOLS) reported earnings yield of -16.3% in Q1 2026.
How has Evolus's earnings yield changed year-over-year?
Evolus's earnings yield decreased by 121.7% year-over-year, from -7.3% to -16.3%.
What is the long-term trend for Evolus's earnings yield?
Over 5 years (2020 to 2025), Evolus's earnings yield has grown at a -32.7% compound annual growth rate (CAGR), from -87.3% to -12%.
What does earnings yield mean?
Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.